Frailty as a Marker for the Plasma Concentrations of Direct Oral Anticoagulants in Older Patients: Results of an Exploratory Study.

Annette EidamJulian MarjiPetra BenzingerKathrin I FoersterJürgen BurhenneDavid CzockFelicitas StollAntje BlankGerd MikusWalter E HaefeliJürgen M Bauer

Published in: Drugs & aging (2023)

German Clinical Trials Register DRKS00016741; registered 20 February, 2019.

Keyphrases

direct oral anticoagulants
clinical trial
venous thromboembolism
atrial fibrillation
community dwelling
phase ii
open label
phase iii